Jinkun Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jinkun Xu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Changkai Hou
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Xicheng District, Beijing, China
2 shared publications - Guoguang Zhao
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
2 shared publications - Ting Tang
Department of Neurosurgery Xuanwu Hospital, Capital medical University Beijing China
2 shared publications - Yumin Luo
Department of Neurosurgery Xuanwu Hospital, Capital medical University Beijing China
2 shared publications - Bangyue Wang
Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
1 shared publication Bin Fu
Department of Neurosurgery Xuanwu Hospital Capital Medical University Beijing China
1 shared publication
Latest Publications
- 8 February 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (5) , 1102-1118
Perivascular macrophage depletion impairs glymphatic clearance and amplifies cortical hyperexcitability: Preclinical insights with clinical validation
Perivascular macrophages (PVMs) are increasingly recognized as key players in maintaining brain homeostasis, yet their role in maintaining neurovascular–metabolic homeostasis has not been fully explored. We hypothesized that PVM depletion compromises cerebrospinal fluid-interstitial fluid exchange through glymphatic system (GS) dysfunction, thereby exacerbating cortical hyperexcitability manifested as increased epilepsy susceptibility and seizure intensity. Using clodronate liposomes (CLOs), we achieved >85% PVM depletion in mice. Following pentylenetetrazole (PTZ) challenge, PVM-depleted mice exhibited anxiety-like behaviors (reduced center time, p < 0.05), impaired working memory (decreased spontaneous alternation, p < 0.05), and increased cortical hyperexcitability, including shorter seizure latency and elevated EEG total power ( p < 0.05). Mechanistically, PVM loss led to dysregulation of extracellular matrix components (increased laminin and collagen IV), impairing perivascular space integrity and GS function (reduced CSF tracer clearance, p < 0.05). AQP4 inhibition with TGN-020 further exacerbated PTZ-induced EEG abnormalities (increased total power, p < 0.05). Analysis of human epileptic tissue confirmed elevated collagen IV deposition in the seizure focus ( p < 0.05) and a trend toward increased PVM density ( p = 0.0638). These results highlight PVMs as essential modulators of the glymphatic–metabolic axis, linking vascular health to brain excitability. Targeting the PVM–GS interface offers therapeutic potential for disorders involving vascular dysfunction and neuronal hyperexcitability.
- 8 February 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (5) , 1102-1118
Perivascular macrophage depletion impairs glymphatic clearance and amplifies cortical hyperexcitability: Preclinical insights with clinical validation
Perivascular macrophages (PVMs) are increasingly recognized as key players in maintaining brain homeostasis, yet their role in maintaining neurovascular–metabolic homeostasis has not been fully explored. We hypothesized that PVM depletion compromises cerebrospinal fluid-interstitial fluid exchange through glymphatic system (GS) dysfunction, thereby exacerbating cortical hyperexcitability manifested as increased epilepsy susceptibility and seizure intensity. Using clodronate liposomes (CLOs), we achieved >85% PVM depletion in mice. Following pentylenetetrazole (PTZ) challenge, PVM-depleted mice exhibited anxiety-like behaviors (reduced center time, p < 0.05), impaired working memory (decreased spontaneous alternation, p < 0.05), and increased cortical hyperexcitability, including shorter seizure latency and elevated EEG total power ( p < 0.05). Mechanistically, PVM loss led to dysregulation of extracellular matrix components (increased laminin and collagen IV), impairing perivascular space integrity and GS function (reduced CSF tracer clearance, p < 0.05). AQP4 inhibition with TGN-020 further exacerbated PTZ-induced EEG abnormalities (increased total power, p < 0.05). Analysis of human epileptic tissue confirmed elevated collagen IV deposition in the seizure focus ( p < 0.05) and a trend toward increased PVM density ( p = 0.0638). These results highlight PVMs as essential modulators of the glymphatic–metabolic axis, linking vascular health to brain excitability. Targeting the PVM–GS interface offers therapeutic potential for disorders involving vascular dysfunction and neuronal hyperexcitability.
- Open Access
- 31 January 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (2) , e70772
Ablation of Unilateral Hippocampal GABAergic Neurons: A Novel Mouse Model of Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis
Aims: While various animal models of mesial temporal lobe epilepsy (MTLE) exist, a validated model based solely on hippocampal GABAergic interneuron loss is lacking. We aimed to establish and characterize a novel MTLE with hippocampal sclerosis (HS) model by selective ablation of these neurons. Methods: Using AAV vectors (flex‐DTA or DIO‐taCasp3‐TEVp), we performed unilateral, partial ablation of GABAergic neurons in the dentate gyrus (DG) or CA1 subregions of VGAT‐Cre mice. Spontaneous recurrent seizures (SRS) were monitored by video‐EEG. Behavioral tests and histopathological analyses were conducted to assess comorbidities and HS features. Results: DG‐ablated mice all developed SRS, whereas 50%–70% of CA1‐ablated mice did. Lethal SRS occurred in around 50% of DG‐ablated mice. Both ablation models exhibited sustained SRS from Days 8–28, distinct from kainic acid model severity in some parameters. The model recapitulated anxiety‐like behaviors, cognitive deficits, and hallmark HS pathology including gliosis, granule cell dispersion, and mossy fiber sprouting. Conclusion: Selective unilateral hippocampal GABAergic interneuron loss is sufficient to drive chronic epilepsy with HS. This model provides direct causal evidence and a precise platform for investigating MTLE‐HS mechanisms and therapies.
- 31 January 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (2) , e70772
Open AccessAblation of Unilateral Hippocampal GABAergic Neurons: A Novel Mouse Model of Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis
Aims: While various animal models of mesial temporal lobe epilepsy (MTLE) exist, a validated model based solely on hippocampal GABAergic interneuron loss is lacking. We aimed to establish and characterize a novel MTLE with hippocampal sclerosis (HS) model by selective ablation of these neurons. Methods: Using AAV vectors (flex‐DTA or DIO‐taCasp3‐TEVp), we performed unilateral, partial ablation of GABAergic neurons in the dentate gyrus (DG) or CA1 subregions of VGAT‐Cre mice. Spontaneous recurrent seizures (SRS) were monitored by video‐EEG. Behavioral tests and histopathological analyses were conducted to assess comorbidities and HS features. Results: DG‐ablated mice all developed SRS, whereas 50%–70% of CA1‐ablated mice did. Lethal SRS occurred in around 50% of DG‐ablated mice. Both ablation models exhibited sustained SRS from Days 8–28, distinct from kainic acid model severity in some parameters. The model recapitulated anxiety‐like behaviors, cognitive deficits, and hallmark HS pathology including gliosis, granule cell dispersion, and mossy fiber sprouting. Conclusion: Selective unilateral hippocampal GABAergic interneuron loss is sufficient to drive chronic epilepsy with HS. This model provides direct causal evidence and a precise platform for investigating MTLE‐HS mechanisms and therapies.